Aethlon Medical (AEMD) EBITDA Margin (2011 - 2023)
Aethlon Medical (AEMD) posted EBITDA Margin of 431.51% for Q1 2023, up 98.5% on a QoQ basis from 28863.21% in Q1 2022, and up 2843170.0% year-over-year from N/an in Q1 2022.
Aethlon Medical (AEMD) EBITDA Margin (2011 - 2023) Analysis & Trends
Aethlon Medical's EBITDA Margin history runs 13 years deep, the most recent figure standing at 431.51% for Q1 2023.
- Quarterly EBITDA Margin rose 2843170.0% year-over-year to 431.51% in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 2072.12% (up 147041.0% YoY) and the FY2023 annual result came in at 2072.05%, up 147048.0% from the prior year.
- EBITDA Margin was 431.51% for Q1 2023 at Aethlon Medical, up from 28863.21% in the prior quarter.
- Across five years, EBITDA Margin topped out at 211.97% in Q4 2019 and bottomed at 28863.21% in Q1 2022.
- A 5-year average of 5678.8% and a median of 1590.14% in 2021 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin plunged 2224803 bps — and 2023, when it surged 2843170 bps.
- Aethlon Medical's EBITDA Margin stood at 211.97% in 2019, then slumped by 85 bps to 391.18% in 2020, then plunged by 3675 bps to 14768.63% in 2021, then tumbled by 95 bps to 28863.21% in 2022, then soared by 99 bps to 431.51% in 2023.
- Business Quant data shows AEMD's EBITDA Margin at 431.51% in Q1 2023, 28863.21% in Q1 2022, and 14768.63% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 10.04% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 21.42% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 6.17% |
| 10 | Aethlon Medical | 401,266.84 | 401,266.84 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -431.51% |
| Mar 31, 2022 | -28,863.21% |
| Dec 31, 2021 | -14,768.63% |
| Sep 30, 2021 | -1,522.21% |
| Jun 30, 2021 | -1,590.14% |
| Mar 31, 2021 | -6,615.18% |
| Dec 31, 2020 | -391.18% |
| Mar 31, 2020 | -863.54% |
| Dec 31, 2019 | -211.97% |
| Jun 30, 2019 | -5,220.63% |
| Mar 31, 2019 | -1,988.65% |
| Jun 30, 2018 | -733.35% |
| Mar 31, 2018 | -1,699.01% |
| Dec 31, 2017 | -1,555.38% |
| Sep 30, 2016 | -574.72% |
| Jun 30, 2016 | -24,415.36% |
| Mar 31, 2016 | -530.81% |
| Dec 31, 2015 | -360.14% |
| Sep 30, 2015 | -596.90% |
| Jun 30, 2015 | -566.20% |